TNF and type 2 diabetes mellitus: TNF-α concentrations employed in vitro are often much higher than the plasma concentrations found in human patients with obesity and type 2 diabetes, and therefore it may be difficult to extrapolate from findings obtained in vitro to in vivo [6, 28].